Top 100 Contractors in PSC AN13: Health R&D Services; Health Care Services; Experimental Development, FY2024

Parent companies by net contract obligations Oct 1, 2023 – Sep 30, 2024 Code page on GovTribe

The top 10 won 66% of FY2024 PSC AN13 contract dollars

Ranking facts

Contract obligations
$532,065,245 Net of deobligations, by contracts coded PSC AN13
Contractors
103 Parent companies with an obligation
Largest contractor
Amgen USA Inc $130 million, 18.5% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $129,850,668
Rank history: not on the FY2021–FY2023 lists and #1 in FY2025; new.
2 $112,552,320
Rank history: #1 in FY2021, #6 in FY2022, #3 in FY2023 and #2 in FY2025; up 1 since FY2023.
3 $51,049,267
Rank history: not on the FY2021–FY2022 lists, #5 in FY2023 and not on the FY2025 list; up 2 since FY2023.
4 $41,766,931
Rank history: not on the FY2021–FY2023 lists and #20 in FY2025; new.
5 $23,887,628
Rank history: not on the FY2021 list, #25 in FY2022, #28 in FY2023 and #7 in FY2025; up 23 since FY2023.
6 $22,500,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
7 $21,890,450
Rank history: not on the FY2021 list, #12 in FY2022, #13 in FY2023 and #9 in FY2025; up 6 since FY2023.
8 $20,597,670
Rank history: not on the FY2021–FY2023 lists and #18 in FY2025; new.
9 $20,087,478
Rank history: not on the FY2021 list, #64 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
10 $16,937,464
Rank history: not on the FY2021–FY2023 lists and #66 in FY2025; new.
11 $12,990,717
Rank history: #45 in FY2021, not on the FY2022–FY2023 lists and not on the FY2025 list; returned.
12 $12,338,740
Rank history: not on the FY2021 list, #15 in FY2022, not on the FY2023 list and #44 in FY2025; returned.
13 $12,271,311
Rank history: not on the FY2021–FY2023 lists and #3 in FY2025; new.
14 $10,616,573
Rank history: #9 in FY2021, #16 in FY2022, #18 in FY2023 and #4 in FY2025; up 4 since FY2023.
15 $10,000,000
Rank history: #10 in FY2021, #27 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
16 $9,917,110
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
17 $9,263,365
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
18 $9,200,000
Rank history: #19 in FY2021, #24 in FY2022, #24 in FY2023 and #32 in FY2025; up 6 since FY2023.
19 $8,900,870
Rank history: not on the FY2021 list, #23 in FY2022, #25 in FY2023 and #34 in FY2025; up 6 since FY2023.
20 $8,742,122
Rank history: not on the FY2021–FY2022 lists, #11 in FY2023 and #6 in FY2025; down 9 since FY2023.
21 $8,096,757
Rank history: #56 in FY2021, not on the FY2022 list, #12 in FY2023 and #72 in FY2025; down 9 since FY2023.
22 $7,490,707
Rank history: #15 in FY2021, #81 in FY2022, #35 in FY2023 and #16 in FY2025; up 13 since FY2023.
23 $7,000,000
Rank history: #5 in FY2021, #13 in FY2022, #9 in FY2023 and not on the FY2025 list; down 14 since FY2023.
24 $5,000,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
25 $4,974,417
Rank history: #52 in FY2021, #29 in FY2022, #94 in FY2023 and not on the FY2025 list; up 69 since FY2023.
26
Aptargroup Inc. Through CSP Technologies, Inc.
$4,858,871
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
27 $4,530,514
Rank history: not on the FY2021 list, #14 in FY2022, #36 in FY2023 and not on the FY2025 list; up 9 since FY2023.
28 $4,455,418
Rank history: not on the FY2021 list, #18 in FY2022, #29 in FY2023 and not on the FY2025 list; up 1 since FY2023.
29
Johnson & Johnson 2 awardees, including Janssen Research & Development, LLC
$4,073,169
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
30 $3,814,216
Rank history: not on the FY2021–FY2022 lists, #74 in FY2023 and not on the FY2025 list; up 44 since FY2023.
31 $3,619,794
Rank history: not on the FY2021–FY2022 lists, #92 in FY2023 and not on the FY2025 list; up 61 since FY2023.
32
Danaher Corporation Through Cepheid
$3,576,000
Rank history: not on the FY2021–FY2023 lists and #14 in FY2025; new.
33 $3,542,000
Rank history: not on the FY2021–FY2023 lists and #31 in FY2025; new.
34 $3,499,999
Rank history: not on the FY2021–FY2022 lists, #67 in FY2023 and not on the FY2025 list; up 33 since FY2023.
35
Iqvia Government Solutions Inc
$3,322,007
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
36 $3,196,979
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
37 $3,042,751
Rank history: not on the FY2021–FY2022 lists, #47 in FY2023 and not on the FY2025 list; up 10 since FY2023.
38 $2,425,998
Rank history: #31 in FY2021, #22 in FY2022, #46 in FY2023 and #23 in FY2025; up 8 since FY2023.
39 $2,400,000
Rank history: not on the FY2021 list, #28 in FY2022, not on the FY2023 list and #67 in FY2025; returned.
40 $2,148,974
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
41 $2,065,992
Rank history: #14 in FY2021, #8 in FY2022, #68 in FY2023 and not on the FY2025 list; up 27 since FY2023.
42 $2,000,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
43 $2,000,000
Rank history: not on the FY2021–FY2022 lists, #58 in FY2023 and #64 in FY2025; up 15 since FY2023.
44 $1,872,042
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
45 $1,349,691
Rank history: not on the FY2021 list, #54 in FY2022, #93 in FY2023 and not on the FY2025 list; up 48 since FY2023.
46
UIC Parent Corporation Through Curia Global Inc.
$1,179,279
Rank history: not on the FY2021–FY2022 lists, #70 in FY2023 and #69 in FY2025; up 24 since FY2023.
47 $1,000,000
Rank history: not on the FY2021 list, #55 in FY2022, #72 in FY2023 and #75 in FY2025; up 25 since FY2023.
48 $967,160
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
49
Asgn Incorporated Through ECS Federal, LLC
$848,402
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
50 $843,860
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
51 $777,258
Rank history: not on the FY2021–FY2022 lists, #69 in FY2023 and #73 in FY2025; up 18 since FY2023.
52 $749,999
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
53 $749,999
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
54 $749,999
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
55 $749,998
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
56 $749,926
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
57 $749,900
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
58 $749,846
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
59 $749,700
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
60 $749,627
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
61 $749,289
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
62 $749,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
63 $748,997
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
64 $747,398
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
65 $742,100
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
66 $733,900
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
67 $733,720
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
68 $733,382
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
69 $732,813
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
70 $665,355
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
71 $613,200
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
72 $600,000
Rank history: not on the FY2021–FY2023 lists and #57 in FY2025; new.
73 $599,995
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
74 $599,601
Rank history: not on the FY2021–FY2023 lists and #58 in FY2025; new.
75 $597,544
Rank history: not on the FY2021–FY2022 lists, #41 in FY2023 and #55 in FY2025; down 34 since FY2023.
76 $597,456
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
77 $594,676
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
78 $565,397
Rank history: not on the FY2021–FY2023 lists and #12 in FY2025; new.
79 $404,607
Rank history: not on the FY2021 list, #93 in FY2022, #54 in FY2023 and not on the FY2025 list; down 25 since FY2023.
80 $393,544
Rank history: #11 in FY2021, #21 in FY2022, #27 in FY2023 and #35 in FY2025; down 53 since FY2023.
81 $369,926
Rank history: not on the FY2021–FY2023 lists and #5 in FY2025; new.
82
Focal Medical Inc.
$297,965
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
83 $257,750
Rank history: not on the FY2021–FY2022 lists, #99 in FY2023 and #92 in FY2025; up 16 since FY2023.
84 $178,948
Rank history: not on the FY2021–FY2023 lists and #52 in FY2025; new.
85 $160,175
Rank history: not on the FY2021–FY2022 lists, #50 in FY2023 and #49 in FY2025; down 35 since FY2023.
86 $100,000
Rank history: not on the FY2021 list, #89 in FY2022, not on the FY2023 list and #93 in FY2025; up 21 since FY2023.
87 $81,515
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
88
King'S College London
$70,400
Rank history: not on the FY2021–FY2023 lists and #94 in FY2025; up 17 since FY2023.
89 $66,010
Rank history: not on the FY2021–FY2023 lists and #56 in FY2025; new.
90 $65,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
91 $28,781
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
92
Eurofins EAG Agroscience LLC Through Eurofins Discoverx LLC
$20,835
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
93 $16,151
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
94 $15,380
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
95 $15,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 14 since FY2023.
96 $13,062
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
97
Xenobiotic Laboratories Inc
$13,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 9 since FY2023.
98 $6,399
Rank history: not on the FY2021 list, #26 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
99 $5,760
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
100 $3,500
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 12 since FY2023.
Show 75 more

100 of 103 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $700 million obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2024 ran Oct 1, 2023 – Sep 30, 2024. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2023. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2023 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC AN13 contractors in FY2024?

1. Amgen USA Inc ($130M), 2. Siga Technologies, Inc. ($113M), 3. Modex Therapeutics, Inc. ($51M), 4. Emergent Biosolutions Inc. ($41.8M), 5. Locus Biosciences Inc. ($23.9M), 6. Pattern Bioscience, Inc. ($22.5M), 7. Westat, Inc. ($21.9M), 8. 4J Therapeutics Inc. ($20.6M), 9. 3M Company ($20.1M), 10. Synedgen, Inc. ($16.9M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work